Prenetics Global Limited (PRE)
NASDAQ: PRE · IEX Real-Time Price · USD
4.790
+0.220 (4.81%)
At close: Apr 24, 2024, 4:00 PM
4.960
+0.170 (3.55%)
After-hours: Apr 24, 2024, 6:53 PM EDT
Company Description
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment.
It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test.
The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.
In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco.
Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
Prenetics Global Limited
| Country | Hong Kong |
| Founded | 2014 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 400 |
| CEO | Sheng Wu Yeung |
Contact Details
Address: 7/f, K11 Atelier, 728 King's Road Quarry Bay, K3 000000 Hong Kong | |
| Phone | (852) 2210-7188 |
| Website | prenetics.com |
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245106 |
| ISIN Number | KYG722451229 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Sheng Wu Yeung | Co-Founder, Chairperson and Chief Executive Officer |
| Dr. Chi Hung Tzang Ph.D. | Co-Founder, Chief Scientific Officer and Member of Scientific Advisory Board |
| Hoi Chun Lo | Chief Financial Officer |
| Dr. Yung Ho Wong DPHIL | Chief Technology Officer |
| Samantha Kwok | Chief of Staff to Group Chief Executive Officer and Vice President, People & Operations |
| Dr. Senthil Sundaram M.D. | Chief Clinical Officer |
| Joel Neoh | Chief Consumer Officer and Chief Executive Officer for CircleDNA |
| Walt Ling | Chief Executive Officer of ACT Genomics |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2024 | 6-K | Report of foreign issuer |
| Feb 16, 2024 | EFFECT | Notice of Effectiveness |
| Feb 16, 2024 | 424B3 | Prospectus |
| Feb 5, 2024 | F-3/A | Filing |
| Feb 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 26, 2024 | UPLOAD | Filing |
| Jan 17, 2024 | F-3 | Filing |
| Nov 30, 2023 | 6-K | Report of foreign issuer |
| Nov 27, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 20, 2023 | 6-K | Report of foreign issuer |